Boston Scientific device recall labeled Class I | FTC to block $8.5B Capri takeover | Kraft Heinz sued over Lunchables contamination
In today’s Portfolio Intelligence Daily, where we highlight non-financial risks lurking under the radar with private companies and equities worldwide:?
Our analyst team curates these summaries from Auquan’s Intelligence Engine, which uses generative AI and retrieval augmented generation (RAG) to uncover material non-financial insights at scale, such as emerging reputational risks of private companies and global supply chains.
The latest news from Auquan:?
Boston Scientific device recall labeled Class I
Boston Scientific's Obsidio Embolic device recall is classified by the FDA as "most serious" due to heightened risk of bowel ischemia during GI bleeding procedures; Boston advises against a specific technique.
Select timeline
FTC to block $8.5B Capri takeover
Tapestry's $8.5 billion acquisition of Capri, owner of Michael Kors, faces FTC opposition despite EU and Japan approvals.
领英推荐
Select timeline
Kraft Heinz sued over lead and cadmium contamination in Lunchables products
Consumer Reports, an advocacy group, petitions USDA to remove Kraft Heinz's Lunchables from the National School Lunch Program due to high lead, cadmium, and sodium levels, along with Phthalates.
Select timeline
While you’re here…
If you find insights like these interesting, smash that subscribe button!?
If you’d like a deeper non-financial risk and opportunity analysis of any of the companies covered here — or that you’re focused on, let us know.?
We’d love to show you how Auquan’s Intelligence Engine can help you transform private company research for deal sourcing, due diligence, risk monitoring, sustainability, and compliance. Let’s talk!
#genai #privatequity #privatecredit #privatemarkets #fintech #duediligence #esg #rag